YALE UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1701-10-09
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.yale.edu
Guanfacine to Improve Substance Use Outcomes in Women
Phase 2
Completed
- Conditions
- Substance Use Disorders
- Interventions
- Other: Behavioral Counseling
- First Posted Date
- 2019-06-10
- Last Posted Date
- 2024-03-20
- Lead Sponsor
- Yale University
- Target Recruit Count
- 74
- Registration Number
- NCT03980184
- Locations
- 🇺🇸
The Yale Stress Center: Yale University, New Haven, Connecticut, United States
Dronabinol for Pain and Inflammation in Adults Living With Sickle Cell Disease
Phase 1
Terminated
- Conditions
- Sickle Cell Disease
- Interventions
- First Posted Date
- 2019-06-06
- Last Posted Date
- 2021-01-26
- Lead Sponsor
- Yale University
- Target Recruit Count
- 6
- Registration Number
- NCT03978156
- Locations
- 🇺🇸
Yale New Haven Hospital Smilow Cancer Center, New Haven, Connecticut, United States
Periarticular Injection Versus Peripheral Nerve Block in Total Hip Arthroplasty
Phase 2
Completed
- Conditions
- Hip Arthropathy
- Interventions
- First Posted Date
- 2019-06-06
- Last Posted Date
- 2022-09-23
- Lead Sponsor
- Yale University
- Target Recruit Count
- 192
- Registration Number
- NCT03977454
- Locations
- 🇺🇸
Yale-New Haven Hospital St Raphael, New Haven, Connecticut, United States
The Effect of Glucagon on Rates of Hepatic Mitochondrial Oxidation in Man Assessed by PINTA
- First Posted Date
- 2019-05-28
- Last Posted Date
- 2024-11-26
- Lead Sponsor
- Yale University
- Target Recruit Count
- 10
- Registration Number
- NCT03965130
- Locations
- 🇺🇸
Yale Hospital reserach Unit / YCCI, New Haven, Connecticut, United States
Evaluation and Management of Metabolic Bone Disease in Kidney Transplant Recipients
Not Applicable
Completed
- Conditions
- Kidney Transplant; ComplicationsSkeletal Anomalies
- Interventions
- Diagnostic Test: measurements to evaluate metabolic bone diseaseDiagnostic Test: standard care
- First Posted Date
- 2019-05-22
- Last Posted Date
- 2023-02-28
- Lead Sponsor
- Yale University
- Target Recruit Count
- 8
- Registration Number
- NCT03958409
- Locations
- 🇺🇸
Yale Transplantation Center/Yale-New Haven Hospital, New Haven, Connecticut, United States
Approaches to Reduce Clinical Inertia in Hypertension in the Dominican Republic
Not Applicable
Withdrawn
- Conditions
- Hypertension
- Interventions
- Other: Multimodality behavioral strategy
- First Posted Date
- 2019-05-17
- Last Posted Date
- 2020-03-02
- Lead Sponsor
- Yale University
- Registration Number
- NCT03954951
- Locations
- 🇩🇴
Instituto Tecnologico de Santo Domingo, Santo Domingo, Dominican Republic
The Role of Neuroactive Steroids in Stress, Drug Craving and Drug Use in Cocaine Use Disorders
Early Phase 1
Completed
- Conditions
- Cocaine-Related Disorders
- Interventions
- Drug: Placebos
- First Posted Date
- 2019-05-16
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Yale University
- Target Recruit Count
- 58
- Registration Number
- NCT03953612
- Locations
- 🇺🇸
Yale Stress Center, New Haven, Connecticut, United States
Preventing Childhood Obesity Through a Mindfulness-Based Parent Stress Intervention
Not Applicable
Active, not recruiting
- Conditions
- Child Obesity
- Interventions
- Behavioral: Contact Control Nutrition (C+N)Other: Non-randomized historical control (WLC) assessment onlyBehavioral: Parenting Mindfully for Health Nutrition (PMH)
- First Posted Date
- 2019-05-15
- Last Posted Date
- 2024-02-15
- Lead Sponsor
- Yale University
- Target Recruit Count
- 246
- Registration Number
- NCT03950453
- Locations
- 🇺🇸
The Yale Stress Center: Yale University, New Haven, Connecticut, United States
Text Messaging in Patients on Adjuvant Endocrine Therapy for Breast Cancer
Not Applicable
Completed
- Conditions
- Side EffectBreast CancerAdherence, Medication
- Interventions
- Behavioral: BETA-Text text messaging intervention
- First Posted Date
- 2019-05-14
- Last Posted Date
- 2023-11-28
- Lead Sponsor
- Yale University
- Target Recruit Count
- 400
- Registration Number
- NCT03949270
- Locations
- 🇺🇸
Yale Cancer Center, New Haven, Connecticut, United States
Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Medication Change for Non-Responders
Phase 2
Completed
- Conditions
- Binge-Eating DisorderObesity
- Interventions
- Other: Placebo
- First Posted Date
- 2019-05-10
- Last Posted Date
- 2025-03-07
- Lead Sponsor
- Yale University
- Target Recruit Count
- 3
- Registration Number
- NCT03946111
- Locations
- 🇺🇸
Yale Department of Psychiatry, New Haven, Connecticut, United States
© Copyright 2025. All Rights Reserved by MedPath